dipyridamole has been researched along with Shock in 4 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a case of fulminant shock and noncardiogenic pulmonary edema induced by intravenously administered dipyridamole." | 7.77 | Dipyridamole-associated shock and pulmonary edema. ( Arias, SA; Dioverti, M; Fishman, R; Lall, P; Manthous, C; Moskowitz, R; Nair, S; Schussheim, AE; Zarich, S, 2011) |
| "This is the first case report of a circulatory collapse induced by an oral intake of dipyridamole." | 5.48 | Oral Dipyridamole-Associated Circulatory Collapse. ( Jolma, P; Ollikainen, J; Uurto, I, 2018) |
| " The reported highest dosage of acute ingestion was 1250 mg." | 5.29 | Profound shock resulting from a large dose of dipyridamole. ( Chen, JH; Chen, ZC; Kwan, CM, 1994) |
| "To report a case of fulminant shock and noncardiogenic pulmonary edema induced by intravenously administered dipyridamole." | 3.77 | Dipyridamole-associated shock and pulmonary edema. ( Arias, SA; Dioverti, M; Fishman, R; Lall, P; Manthous, C; Moskowitz, R; Nair, S; Schussheim, AE; Zarich, S, 2011) |
| "This is the first case report of a circulatory collapse induced by an oral intake of dipyridamole." | 1.48 | Oral Dipyridamole-Associated Circulatory Collapse. ( Jolma, P; Ollikainen, J; Uurto, I, 2018) |
| " The reported highest dosage of acute ingestion was 1250 mg." | 1.29 | Profound shock resulting from a large dose of dipyridamole. ( Chen, JH; Chen, ZC; Kwan, CM, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jolma, P | 1 |
| Ollikainen, J | 1 |
| Uurto, I | 1 |
| Dioverti, M | 1 |
| Fishman, R | 1 |
| Moskowitz, R | 1 |
| Arias, SA | 1 |
| Nair, S | 1 |
| Lall, P | 1 |
| Schussheim, AE | 1 |
| Zarich, S | 1 |
| Manthous, C | 1 |
| Chen, ZC | 1 |
| Kwan, CM | 1 |
| Chen, JH | 1 |
| Vincent, JL | 1 |
| Brimioulle, S | 1 |
| Berre, J | 1 |
| Kahn, RJ | 1 |
1 trial available for dipyridamole and Shock
| Article | Year |
|---|---|
Prevention of the adult respiratory distress syndrome with dipyridamole.
Topics: Adult; Aged; Dipyridamole; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; P | 1985 |
3 other studies available for dipyridamole and Shock
| Article | Year |
|---|---|
Oral Dipyridamole-Associated Circulatory Collapse.
Topics: Administration, Oral; Aged; Delayed-Action Preparations; Dipyridamole; Humans; Ischemic Attack, Tran | 2018 |
Dipyridamole-associated shock and pulmonary edema.
Topics: Aged; Dipyridamole; Female; Humans; Infusions, Intravenous; Myocardial Perfusion Imaging; Pulmonary | 2011 |
Profound shock resulting from a large dose of dipyridamole.
Topics: Adult; Aminophylline; Coma; Dipyridamole; Dopamine; Electrocardiography; Female; Humans; Poisoning; | 1994 |